ArticleProcedia computer science2022
Highlighting artificial intelligence roles in business area Amid the COVID-19 crisis.
Article in Procedia computer science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe fast development of technology and data has fueled the use of artificial intelligence (AI) in the business area, but there has been no comprehensive review to guide and assess this evolution, especially in the context of Covid-19 crisis. Our objective is to highlight the nature and scale of AI research in the business area, during the COVID-19 Pandemic.
methodsWe performed a scoping review and searched two literature databases (Scopus and MDPI) for terms related to AI and Covid-19 by focusing on scientific papers published in the field of business. We used multiple tools (Endnote, Covidence) for titles and abstracts selection, followed by full-text screening. The studies must include research on artificial intelligence and Covid-19, and then be published in English-language, between March 2020 and March 2022.
results31 studies met eligibility criteria (of 391 studies selected). Most of the published articles refer to conceptual analysis or quantitative works, the rest of the articles used a literature review except 4 articles published using a qualitative method of analysis. In addition, we observe an evolution of the total number of publications for the 31 articles included in the analysis.
conclusionsStudying AI in the business field amid the covid-19 crisis is at an early stage of maturity, especially with the use of new AI technologies.). For the field to progress, more studies are needed in the next few years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.